Edit Symbol List
PFE: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| 1y Target Est: | $ 20.00 |
| Today's High / Low | / |
| Share Volume | |
| Previous Close | $ 16.40 |
| 52 Wk High / Low | $ 20.36 / $ 14 |
| Shares Outstanding | 8,038,278,000 |
| Market Value of Listed Security | $ 132,310,055,880 |
| P/E Ratio | 7.41 |
| Forward P/E (1yr) | 7.24 |
| Earnings Per Share | $ 2.22 |
| Annualized Dividend | $0.720000 |
| Ex Dividend Date | Aug. 4, 2010 |
| Dividend Payment Date | Sep. 1, 2010 |
| Current Yield | 4.37 % |
| Beta | 0.75 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About PFE?
Ask your question about about Pfizer, Inc. (PFE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Pfizer Inc. (which may be referred to as Pfizer, the Company, we, us or our) is a research-based, global biopharmaceutical company. We apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer health care products. Every day, we work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. ... More ...
Links to all Pfizer, Inc. (PFE) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for PFE
|
||
|
A Fool Looks Back - The Motley Fool 09/04/2010 8:34AM |
||
|
Why You Just Got Hammered - The Motley Fool 09/03/2010 6:55PM |
||
|
FOCUS: Roche To Cut Costs As Austerity Programs, R&D Hurt - Dow Jones Business News 09/03/2010 11:46AM |
||
|
5-Star Stocks Poised to Pop: Gilead Sciences - The Motley Fool 09/03/2010 10:50AM |
||
|
Celldex, Pfizer Split Over Brain Tumor Drug - TheStreet 09/03/2010 9:43AM |
||
Read more PFE News & Commentary |
||
Consensus Recommendation |
|
|
Analyst Info |
|
| Annual EPS Est: | $ 2.21 |
| Quarterly EPS Est: | $ 0.51 |
| PEG Ratio: | 3.65 |
| Mean Recommendation: View Summary/View All |
2.00 |
Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
0.37%
